Sfoglia per Autore
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
2019-01-01 Usmani S.Z.; Schjesvold F.; Oriol A.; Karlin L.; Cavo M.; Rifkin R.M.; Yimer H.A.; LeBlanc R.; Takezako N.; McCroskey R.D.; Lim A.B.M.; Suzuki K.; Kosugi H.; Grigoriadis G.; Avivi I.; Facon T.; Jagannath S.; Lonial S.; Ghori R.U.; Farooqui M.Z.H.; Marinello P.; San-Miguel J.; Lim A.; Walker T.; Nicol A.; Reece D.; Elemary M.; Boudreault Pedneault J.S.; Attal M.; Weisel K.; Engelhardt M.; Mackensen A.; Quinn J.; Cohen A.; Magen-Nativ H.; Benyamini N.; Larocca A.; Matsumoto M.; Iida S.; Ishikawa T.; Kondo Y.; Sunami K.; Ando K.; Teshima T.; Chou T.; Iwasaki H.; Miki H.; Matsumura I.; Onishi Y.; Izutsu K.; Kizaki M.; George A.; Blacklock H.; Simpson D.; Waage A.; Samoilova O.; Nikitin E.; Chagorova T.; McDonald A.; Patel M.; Oriol Rocafiguera A.; San Miguel Izquierdo J.; Mateos M.; Streetly M.; Forsyth P.; Jackson G.; Jenkins S.; Rifkin R.; Yimer H.; McCroskey R.; Martincic D.; Tarantolo S.; Larson S.; Faroun Y.; Vaughn J.; Baz R.; Saylors G.; Neppalli A.; Raptis A.; Fung H.; Janosky M.; Stevens D.; Coleman M.; Costa D.; Cross S.; Fanning S.; Berges D.F.; Harris T.; Zackon I.; Atanackovic D.; Lee K.; Oliff I.; Lee W.; Bensinger W.; Lutzky J.; Baron A.; Hayek F.; Kirschner E.; Bharany N.; Overton L.; Mannem S.; Harroff A.; Jain S.; Roque T.; McIntyre K.; Yasencha C.K.; Houck W.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
2019-01-01 Richardson P.G.; Oriol A.; Beksac M.; Liberati A.M.; Galli M.; Schjesvold F.; Lindsay J.; Weisel K.; White D.; Facon T.; San Miguel J.; Sunami K.; O'Gorman P.; Sonneveld P.; Robak P.; Semochkin S.; Schey S.; Yu X.; Doerr T.; Bensmaine A.; Biyukov T.; Peluso T.; Zaki M.; Anderson K.; Dimopoulos M.; Abildgaard N.; Adler H.; Altuntas F.; Akay O.M.; Amin B.; Anagnostopoulos A.; Anderson L.; Anttila P.; Araujo C.; Arce-Lara C.; Aydin Y.; Basu S.; Battini R.; Beeker T.; Benboubker L.; Ben-Yehuda D.; Blade J.; Blau I.W.; Boccia R.; Burke L.; Byeff P.; Cascavilla N.; Cavo M.; Chantry A.; Charles Y.; Chaudhry A.; Corso A.; Coyne M.; De Arriba F.; Delimpasi S.; Desjardins P.; Dhakal B.; Di Bartolomeo P.; Di Raimondo F.; Durig J.; Engelhardt M.; Escoffre-Barbe M.; Esteves G.; Flogegard M.; Gabrail N.; Gamberi B.; Garrison M.; Gay J.; Gisslinger H.; Goldschmidt H.; Goncalves C.; Gressot L.; Grosicki S.; Hanna W.; Hayden P.; Henriques Bernardo M.M.; Hermann R.; Holden V.; Honkalehto K.; Huben M.; Huffman J.; Hunter H.; Hus M.; Jagasia M.; Jagganath S.; Janakiram M.; Jaiyesimi I.; Jenner M.; Joao C.; Johnson P.; Jurcyszyn A.; Kalayoglu Besisik S.; Kambhampati S.; Kanate A.; Karadogan I.; Khojasteh A.; Kirkel D.; Komarnicki M.; Krauth M.-T.; Kuriakose P.; Larocca A.; Lauri B.; Leleu X.; Lucio P.; Luppi M.; Mangiacavalli S.; Mariette C.; Matsue K.; Mellqvist U.-H.; Mendeleeva L.; Meshad M.; Miller C.; Mohrbacher A.; Moreau P.; Morelli A.M.; Muldur E.; Naassan A.; Nahi H.; Nair R.; O'Dwyer M.; Ongoren Aydin S.; Openshaw T.; O'Rourke T.; Osswald M.; Overton L.; Pati A.; Pavic M.; Pegourie B.; Pehlivan M.; Pierola A.A.; Plesner T.; Pluta A.; Rabin N.; Ramasamy K.; Rambaldi A.; Rodriguez P.; Rollig C.; Rosenblatt J.; Rosenbluth J.; Salomo M.; Samoylova O.; Sastre Moral J.; Sati H.; Selleri C.; Shafeek S.; Shinagawa A.; Sleckman B.; Smith C.; Sonmez M.; Stone C.; Streetly M.; Suzuki K.; Taetle R.; Tafuri A.; Takezako N.; Teke H.U.; Vapaatalo M.; Vassilopoulos G.; Verma A.; Vidito S.; Viterbo L.; Vural F.; Wang X.S.; Yagci M.; Yee A.
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
2019-01-01 Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M.
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients
2018-01-01 Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
2018-01-01 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
2018-01-01 Jo Caers, Laurent Garderet, K. Martin Kortüm, Michael E. O'Dwyer, Niels W.C.J. van de Donk, Mascha Binder, Sandra Maria Dold, Francesca Gay, Jill Corre, Yves Beguin, Heinz Ludwig, Alessandra Larocca, Christoph Driessen, Meletios A. Dimopoulos, Mario Boccadoro, Martin Gramatzki, Sonja Zweegman, Hermann Einsele, Michele Cavo, Hartmut Goldschmidt, Pieter Sonneveld, Michel Delforge, Holger W. Auner, Evangelos Terpos, Monika Engelhardt
Special problems in the management of elderly patients with multiple myeloma
2018-01-01 Gay, Francesca*; Larocca, Alessandra
Frail patients with newly diagnosed multiple myeloma
2018-01-01 Larocca, Alessandra; Palumbo, Antonio
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis
2018-01-01 Bringhen, Sara; Offidani, Massimo; Palmieri, Salvatore; Pisani, Francesco; Rizzi, Rita; Spada, Stefano; Evangelista, Andrea; Di Renzo, Nicola; Musto, Pellegrino; Marcatti, Magda; Vallone, Roberto; Storti, Sergio; Bernardini, Annalisa; Centurioni, Riccardo; Aitini, Enrico; Palmas, Angelo; Annibali, Ombretta; Angelucci, Emanuele; Ferrando, Paola; Baraldi, Anna; Rocco, Stefano; Andriani, Alessandro; Siniscalchi, Agostina; De Stefano, Valerio; Meneghini, Vittorio; Palumbo, Antonio; Grammatico, Sara; Boccadoro, Mario; Larocca, Alessandra*
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma
2018-01-01 Salvini, Marco; Troia, Rossella; Giudice, Davide; Pautasso, Chiara; Boccadoro, Mario; Larocca, Alessandra*
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)
2018-01-01 Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika
Risk Stratification in Newly Diagnosed Transplant Ineligible Multiple Myeloma
2017-01-01 Offidani M.; Corvatta L.; Gentili S.; Aghemo E.; Palumbo A.; Maracci L.; Larocca A.
Emerging drugs and combinations to treat multiple myeloma
2017-01-01 Larocca, Alessandra*; Mina, Roberto; Gay, Francesca; Bringhen, Sara; Boccadoro, Mario
Novel investigational drugs active as single agents in multiple myeloma
2017-01-01 D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca
Haemopoietic diseases: leukaemias and myelomas
2017-01-01 Roberto Mina, Alessandra Larocca, Antonio Palumbo
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma
2017-01-01 Offidani, Massimo; Corvatta, Laura; Bringhen, Sara; Gentili, Silvia; Troia, Rossella; Maracci, Laura; Larocca, Alessandra; Gay, Francesca; Leoni, Pietro; Boccadoro, Mario
Elderly patients with multiple myeloma: Towards a frailty approach?
2017-01-01 Sonja Zweegman, Monika Engelhardt, Alessandra Larocca
How is patient care for multiple myeloma advancing?
2017-01-01 Genadieva Stavric, Sonja; Bonello, Francesca; Bringhen, Sara; Boccadoro, Mario; Larocca, Alessandra
Melphalan hydrochloride for the treatment of multiple myeloma
2017-01-01 Esma, Fabrizio; Salvini, Marco; Troia, Rossella; Boccadoro, Mario; Larocca, Alessandra; Pautasso, Chiara*
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
2017-01-01 Gentile, Massimo; Magarotto, Valeria; Offidani, Massimo; Musto, Pellegrino; Bringhen, Sara; Teresa Petrucci, Maria; Gay, Francesca; Larocca, Alessandra; Uccello, Giuseppina; Petrungaro, Annamaria; Vigna, Ernesto; Greco, Rosa; Grazia Recchia, Anna; Tripepi, Giovanni; Ria, Roberto; Di Raimondo, Francesco; Palumbo, Antonio; Morabito, Fortunato
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial | 2019 | Usmani S.Z.; Schjesvold F.; Oriol A.; Karlin L.; Cavo M.; Rifkin R.M.; Yimer H.A.; LeBlanc R.; Takezako N.; McCroskey R.D.; Lim A.B.M.; Suzuki K.; Kosugi H.; Grigoriadis G.; Avivi I.; Facon T.; Jagannath S.; Lonial S.; Ghori R.U.; Farooqui M.Z.H.; Marinello P.; San-Miguel J.; Lim A.; Walker T.; Nicol A.; Reece D.; Elemary M.; Boudreault Pedneault J.S.; Attal M.; Weisel K.; Engelhardt M.; Mackensen A.; Quinn J.; Cohen A.; Magen-Nativ H.; Benyamini N.; Larocca A.; Matsumoto M.; Iida S.; Ishikawa T.; Kondo Y.; Sunami K.; Ando K.; Teshima T.; Chou T.; Iwasaki H.; Miki H.; Matsumura I.; Onishi Y.; Izutsu K.; Kizaki M.; George A.; Blacklock H.; Simpson D.; Waage A.; Samoilova O.; Nikitin E.; Chagorova T.; McDonald A.; Patel M.; Oriol Rocafiguera A.; San Miguel Izquierdo J.; Mateos M.; Streetly M.; Forsyth P.; Jackson G.; Jenkins S.; Rifkin R.; Yimer H.; McCroskey R.; Martincic D.; Tarantolo S.; Larson S.; Faroun Y.; Vaughn J.; Baz R.; Saylors G.; Neppalli A.; Raptis A.; Fung H.; Janosky M.; Stevens D.; Coleman M.; Costa D.; Cross S.; Fanning S.; Berges D.F.; Harris T.; Zackon I.; Atanackovic D.; Lee K.; Oliff I.; Lee W.; Bensinger W.; Lutzky J.; Baron A.; Hayek F.; Kirschner E.; Bharany N.; Overton L.; Mannem S.; Harroff A.; Jain S.; Roque T.; McIntyre K.; Yasencha C.K.; Houck W. | |
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial | 2019 | Richardson P.G.; Oriol A.; Beksac M.; Liberati A.M.; Galli M.; Schjesvold F.; Lindsay J.; Weisel K.; White D.; Facon T.; San Miguel J.; Sunami K.; O'Gorman P.; Sonneveld P.; Robak P.; Semochkin S.; Schey S.; Yu X.; Doerr T.; Bensmaine A.; Biyukov T.; Peluso T.; Zaki M.; Anderson K.; Dimopoulos M.; Abildgaard N.; Adler H.; Altuntas F.; Akay O.M.; Amin B.; Anagnostopoulos A.; Anderson L.; Anttila P.; Araujo C.; Arce-Lara C.; Aydin Y.; Basu S.; Battini R.; Beeker T.; Benboubker L.; Ben-Yehuda D.; Blade J.; Blau I.W.; Boccia R.; Burke L.; Byeff P.; Cascavilla N.; Cavo M.; Chantry A.; Charles Y.; Chaudhry A.; Corso A.; Coyne M.; De Arriba F.; Delimpasi S.; Desjardins P.; Dhakal B.; Di Bartolomeo P.; Di Raimondo F.; Durig J.; Engelhardt M.; Escoffre-Barbe M.; Esteves G.; Flogegard M.; Gabrail N.; Gamberi B.; Garrison M.; Gay J.; Gisslinger H.; Goldschmidt H.; Goncalves C.; Gressot L.; Grosicki S.; Hanna W.; Hayden P.; Henriques Bernardo M.M.; Hermann R.; Holden V.; Honkalehto K.; Huben M.; Huffman J.; Hunter H.; Hus M.; Jagasia M.; Jagganath S.; Janakiram M.; Jaiyesimi I.; Jenner M.; Joao C.; Johnson P.; Jurcyszyn A.; Kalayoglu Besisik S.; Kambhampati S.; Kanate A.; Karadogan I.; Khojasteh A.; Kirkel D.; Komarnicki M.; Krauth M.-T.; Kuriakose P.; Larocca A.; Lauri B.; Leleu X.; Lucio P.; Luppi M.; Mangiacavalli S.; Mariette C.; Matsue K.; Mellqvist U.-H.; Mendeleeva L.; Meshad M.; Miller C.; Mohrbacher A.; Moreau P.; Morelli A.M.; Muldur E.; Naassan A.; Nahi H.; Nair R.; O'Dwyer M.; Ongoren Aydin S.; Openshaw T.; O'Rourke T.; Osswald M.; Overton L.; Pati A.; Pavic M.; Pegourie B.; Pehlivan M.; Pierola A.A.; Plesner T.; Pluta A.; Rabin N.; Ramasamy K.; Rambaldi A.; Rodriguez P.; Rollig C.; Rosenblatt J.; Rosenbluth J.; Salomo M.; Samoylova O.; Sastre Moral J.; Sati H.; Selleri C.; Shafeek S.; Shinagawa A.; Sleckman B.; Smith C.; Sonmez M.; Stone C.; Streetly M.; Suzuki K.; Taetle R.; Tafuri A.; Takezako N.; Teke H.U.; Vapaatalo M.; Vassilopoulos G.; Verma A.; Vidito S.; Viterbo L.; Vural F.; Wang X.S.; Yagci M.; Yee A. | |
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension | 2019 | Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M. | |
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients | 2018 | Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario | |
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) | 2018 | Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt | |
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when | 2018 | Jo Caers, Laurent Garderet, K. Martin Kortüm, Michael E. O'Dwyer, Niels W.C.J. van de Donk, Mascha Binder, Sandra Maria Dold, Francesca Gay, Jill Corre, Yves Beguin, Heinz Ludwig, Alessandra Larocca, Christoph Driessen, Meletios A. Dimopoulos, Mario Boccadoro, Martin Gramatzki, Sonja Zweegman, Hermann Einsele, Michele Cavo, Hartmut Goldschmidt, Pieter Sonneveld, Michel Delforge, Holger W. Auner, Evangelos Terpos, Monika Engelhardt | |
Special problems in the management of elderly patients with multiple myeloma | 2018 | Gay, Francesca*; Larocca, Alessandra | |
Frail patients with newly diagnosed multiple myeloma | 2018 | Larocca, Alessandra; Palumbo, Antonio | |
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis | 2018 | Bringhen, Sara; Offidani, Massimo; Palmieri, Salvatore; Pisani, Francesco; Rizzi, Rita; Spada, Stefano; Evangelista, Andrea; Di Renzo, Nicola; Musto, Pellegrino; Marcatti, Magda; Vallone, Roberto; Storti, Sergio; Bernardini, Annalisa; Centurioni, Riccardo; Aitini, Enrico; Palmas, Angelo; Annibali, Ombretta; Angelucci, Emanuele; Ferrando, Paola; Baraldi, Anna; Rocco, Stefano; Andriani, Alessandro; Siniscalchi, Agostina; De Stefano, Valerio; Meneghini, Vittorio; Palumbo, Antonio; Grammatico, Sara; Boccadoro, Mario; Larocca, Alessandra* | |
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma | 2018 | Salvini, Marco; Troia, Rossella; Giudice, Davide; Pautasso, Chiara; Boccadoro, Mario; Larocca, Alessandra* | |
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) | 2018 | Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika | |
Risk Stratification in Newly Diagnosed Transplant Ineligible Multiple Myeloma | 2017 | Offidani M.; Corvatta L.; Gentili S.; Aghemo E.; Palumbo A.; Maracci L.; Larocca A. | |
Emerging drugs and combinations to treat multiple myeloma | 2017 | Larocca, Alessandra*; Mina, Roberto; Gay, Francesca; Bringhen, Sara; Boccadoro, Mario | |
Novel investigational drugs active as single agents in multiple myeloma | 2017 | D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca | |
Haemopoietic diseases: leukaemias and myelomas | 2017 | Roberto Mina, Alessandra Larocca, Antonio Palumbo | |
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma | 2017 | Offidani, Massimo; Corvatta, Laura; Bringhen, Sara; Gentili, Silvia; Troia, Rossella; Maracci, Laura; Larocca, Alessandra; Gay, Francesca; Leoni, Pietro; Boccadoro, Mario | |
Elderly patients with multiple myeloma: Towards a frailty approach? | 2017 | Sonja Zweegman, Monika Engelhardt, Alessandra Larocca | |
How is patient care for multiple myeloma advancing? | 2017 | Genadieva Stavric, Sonja; Bonello, Francesca; Bringhen, Sara; Boccadoro, Mario; Larocca, Alessandra | |
Melphalan hydrochloride for the treatment of multiple myeloma | 2017 | Esma, Fabrizio; Salvini, Marco; Troia, Rossella; Boccadoro, Mario; Larocca, Alessandra; Pautasso, Chiara* | |
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials | 2017 | Gentile, Massimo; Magarotto, Valeria; Offidani, Massimo; Musto, Pellegrino; Bringhen, Sara; Teresa Petrucci, Maria; Gay, Francesca; Larocca, Alessandra; Uccello, Giuseppina; Petrungaro, Annamaria; Vigna, Ernesto; Greco, Rosa; Grazia Recchia, Anna; Tripepi, Giovanni; Ria, Roberto; Di Raimondo, Francesco; Palumbo, Antonio; Morabito, Fortunato |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile